RERYMDEE
DEAD

Serial Number

99155165

Owner

LONGBOARD PHARMACEUTICALS, INC.

Attorney

Maren Perry

Filing Date

Apr 25, 2025

Add to watchlist:

No watchlists yet
View on USPTO

RERYMDEE Trademark

Serial Number: 99155165

RERYMDEE is a trademark filed by LONGBOARD PHARMACEUTICALS, INC. on April 25, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

LONGBOARD PHARMACEUTICALS, INC. (56 trademarks)

LA JOLLA, CA 92037

Entity Type: 03

Trademark Details

Filing Date

April 25, 2025

Registration Date

Not Registered

Goods & Services

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic preparations for medical use; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases of, generated from or affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the diagnosis, prevention and/or treatment of psychiatric, neurological, neurohormonal, neurogenetic, neuroendocrinological and autoimmune diseases and disorders; pharmaceutical preparations and substances for diagnosis, prevention and treatment of dementia, Alzheimer's disease, depression, psychosis, anxiety, Lennox-Gastaut disease, epilepsy, Dravet Syndrome, Developmental and Epileptic Encephalopathy (DEE), alpha-synucleinopathies, Multiple System Atrophy (MSA), dementia with Lewy bodies, REM sleep behavior syndrome, porphyria, Huntington's disease, insomnia, Parkinson's disease, sclerosis, multiple sclerosis, schizophrenia, bipolar disorder, cancer, pain, migraine, headache, Horton's headache, traumatic brain injury, post-traumatic brain injury, dizziness, seizures, stroke, cognitive impairment, cognitive disorders and diseases, mood disorders, falls, movement disorders and diseases, tremor, agitation, mania, aggression, autism, melancholia, OCD, Tourette's syndrome, restlessness, akathisia, fatigue, somnolence, nausea, Cushing's disease, Adrenogenital syndrome (AGS ), narcolepsy, PTSD, ADHD, PSP, Thyroid Associated Orbitopathy (TAO), Graves Orbitopathy, Hashimoto's Thyroiditis, alcoholism and addiction; preparations, chemical substances, reagents and agents for diagnostic and medical purposes

Surgical and medical apparatus and instruments; apparatus, syringes and needles for injections and medical purposes; apparatus, instruments and articles for diagnostic purposes; devices, instruments and articles for the diagnosis, administration, monitoring, assessment, control and examination of psychiatric, neurological, neurohormonal, neurogenetic, neuroendocrinological and autoimmune disorders and diseases; integrated medical systems comprising medical instruments and software for the examination and assessment of patients and clients; integrated medical systems and instruments for the management, measurement, monitoring, evaluation, control, collection, storage, transmission and examination of patient and client data and information; medical instruments for information, advice, administration and handling of medicinal substances

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 10, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 10, 2026 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 17, 2025 GNRN
NON-FINAL ACTION E-MAILED
Sep 17, 2025 GNRT
NON-FINAL ACTION WRITTEN
Sep 17, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 16, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 3, 2025 NWOS
NEW APPLICATION ENTERED
Apr 25, 2025 NWAP
APPLICATION FILING RECEIPT MAILED
Apr 25, 2025 MAFR